Showing results (121-130 of 314) with videos related to
Sort By:
Pageof 32
Rheumatology (Oxford, England)|January 5, 2019
Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activityRobert Landewé, Christopher T Ritchlin, Daniel Aletaha, et al.The Cochrane Database of Systematic Reviews|January 20, 2012
Pain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondylarthritis) and gastrointestinal or liver comorbidityHelga Radner, Sofia Ramiro, Rachelle Buchbinder, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|March 1, 2023
Improvement or Worsening of Disease Activity After Switch to Sarilumab in Patients With Rheumatoid Arthritis With a Partial Response to AdalimumabJeffrey R Curtis, Daniel Aletaha, Gerd Burmester, et al.Rheumatology (Oxford, England)|November 23, 2014
Relationship between disease activity indices and their individual components and radiographic progression in RA: a systematic literature reviewVictoria Navarro-Compán, Ana Maria Gherghe, Josef S Smolen, et al.Arthritis Research & Therapy|July 1, 2005
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity scoreDaniel Aletaha, Valerie P K Nell, Tanja Stamm, et al.Annals of the Rheumatic Diseases|September 19, 2009
Evaluation of the appropriateness of composite disease activity measures for assessment of psoriatic arthritisValerie P Nell-Duxneuner, Tanja A Stamm, Klaus P Machold, et al.Annals of the Rheumatic Diseases|February 7, 2020
Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?Paul Studenic, David Felson, Maarten de Wit, et al.Arthritis and Rheumatism|September 6, 2005
Remission and active disease in rheumatoid arthritis: defining criteria for disease activity statesDaniel Aletaha, Michael M Ward, Klaus P Machold, et al.Annals of the Rheumatic Diseases|September 26, 2025
Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)Dafne Capelusnik, Clementina Lopez-Medina, Désirée van der Heijde, et al.International Immunology|May 13, 2008
Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)Michael Bonelli, Anastasia Savitskaya, Karolina von Dalwigk, et al.Pageof 32